随机对照试验在建立基于证据的性别平等护理和促进健康公平中的作用。

Q2 Social Sciences

AMA journal of ethics Pub Date : 2024-09-01 DOI:10.1001/amajethics.2024.684

Theodore E Schall, Kaitlyn Jaffe, Jacob D Moses

{"title":"随机对照试验在建立基于证据的性别平等护理和促进健康公平中的作用。","authors":"Theodore E Schall, Kaitlyn Jaffe, Jacob D Moses","doi":"10.1001/amajethics.2024.684","DOIUrl":null,"url":null,"abstract":"This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.","PeriodicalId":38034,"journal":{"name":"AMA journal of ethics","volume":"26 9","pages":"E684-689"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity.\",\"authors\":\"Theodore E Schall, Kaitlyn Jaffe, Jacob D Moses\",\"doi\":\"10.1001/amajethics.2024.684\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.\",\"PeriodicalId\":38034,\"journal\":{\"name\":\"AMA journal of ethics\",\"volume\":\"26 9\",\"pages\":\"E684-689\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMA journal of ethics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/amajethics.2024.684\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Social Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMA journal of ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/amajethics.2024.684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}

引用次数: 0

摘要

本文回顾了最近发表的一项随机对照试验（RCT）的设计，该试验针对的是变性人和性别多样化（TGD）人群立即与延迟获得性别确认激素的问题，并概述了临床医生应该了解的关键学习要点，即 RCT 如何能够以及无法促进变性人和性别多样化（TGD）人群的健康公平。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity.

This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

AMA journal of ethics Social Sciences-Health (social science)

CiteScore

1.90

自引率

0.00%

发文量

146

期刊介绍： The AMA Journal of Ethics exists to help medical students, physicians and all health care professionals navigate ethical decisions in service to patients and society. The journal publishes cases and expert commentary, medical education articles, policy discussions, peer-reviewed articles for journal-based and audio CME, visuals, and more. Since its inception as an editorially-independent journal, we promote ethics inquiry as a public good.